Snapshot from Aug 24, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / People / Paul Chaplin
Person

Paul Chaplin

Tracked across 2 events · 12 articles · First seen Jul 13, 2026 · Last active Aug 07, 2026

Sentiment
15
Attention
4
Events
2
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
Events (2)
4 30
Regulatory
EU Approves Bavarian Nordic Mpox Vaccine for Children
On August 7, 2026, Bavarian Nordic announced that the International — European Commission adopted the CHMP positive opinion and approved a type II variation for its IMVANEX (MVA-BN) smallpox and mpox vaccine, extending the marketing…
Impact: As CEO, Paul Chaplin publicly announced the approval and emphasized its importance for child protection; his leadership is central to Bavarian Nordic's strategy.
Aug 07, 2026 · 6 articles
2 0
Regulatory
Bavarian Nordic chikungunya vaccine submitted in Brazil
Impact: CEO of Bavarian Nordic; commented on the milestone, emphasizing strategy to expand access to endemic regions.
Jul 13, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Paul Chaplin live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.